Načítá se...
Co-stimulatory and co-inhibitory pathways in cancer immunotherapy
Cancer remains the leading cause of death worldwide. Traditional treatments such as surgery, radiation, and chemotherapy have had limited efficacy, especially with late stage cancers. Cancer immunotherapy and targeted therapy have revolutionized how cancer is treated, especially in patients with lat...
Uloženo v:
| Vydáno v: | Adv Cancer Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7336166/ https://ncbi.nlm.nih.gov/pubmed/31202358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/bs.acr.2019.03.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|